141 related articles for article (PubMed ID: 8112781)
1. Platelet serotonin kinetics in acute myocardial infarction before and after thrombolysis.
Chandra M; Chandra N; Gupta S; Varma M; Saxena AK; Kumar A; Shankar K
Indian J Exp Biol; 1993 Dec; 31(12):999-1001. PubMed ID: 8112781
[TBL] [Abstract][Full Text] [Related]
2. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
3. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase.
Wong CK; French JK; Gao W; White HD
Am Heart J; 2003 Jan; 145(1):95-102. PubMed ID: 12514660
[TBL] [Abstract][Full Text] [Related]
4. Platelet cyclic GMP levels in unstable angina and myocardial infarction.
Pistono M; Bergerone S; Carrieri L; Paglia I; Stefano D; Capizzi A; Ferri M; Pescarmona G; Bosia A; Trevi G
Platelets; 2002; 13(5-6):307-11. PubMed ID: 12189017
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis for acute myocardial infarction: drug review.
Cundiff DK
MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
[TBL] [Abstract][Full Text] [Related]
6. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Schins A; Hamulyák K; Scharpé S; Lousberg R; Van Melle J; Crijns H; Honig A
Life Sci; 2004 Dec; 76(6):637-50. PubMed ID: 15567189
[TBL] [Abstract][Full Text] [Related]
7. Platelet function in acute myocardial infarction patients compared with controls.
O'Brien JR; Etherington MD; Shuttleworth RD; Calwell WH
Thromb Haemost; 1980 Oct; 44(2):96-9. PubMed ID: 7455998
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 as a marker of platelet activation in patients with acute myocardial infarction.
Dymicka-Piekarska V; Kemona H; Mantur M; Stogowski A; Kemona-Chetnik I; Bychowski J
Rocz Akad Med Bialymst; 2000; 45():96-103. PubMed ID: 11712446
[TBL] [Abstract][Full Text] [Related]
9. [Observation on plasma serotonin (5-HT) and platelet membrane fluidity in AMI patients].
CHENG HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):456-8. PubMed ID: 2978407
[No Abstract] [Full Text] [Related]
10. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
11. Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction.
Balduini CL; Noris P; Bertolino G; Previtali M
Thromb Haemost; 1993 May; 69(5):522-3. PubMed ID: 8322276
[No Abstract] [Full Text] [Related]
12. Plasma markers of platelet and polymorphonuclear leukocyte activation in young adults with acute myocardial infarction.
Caimi G; Hoffmann E; Montana M; Incalcaterra E; Dispensa F; D'Amico T; Canino B; Lo Presti R
Clin Hemorheol Microcirc; 2005; 32(1):67-74. PubMed ID: 15665428
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
14. Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction.
Serebruany VL; Gurbel PA
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):153-8. PubMed ID: 9888878
[TBL] [Abstract][Full Text] [Related]
15. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon?
Botto N; Sbrana S; Trianni G; Andreassi MG; Ravani M; Rizza A; Al-Jabri A; Palmieri C; Berti S
Int J Cardiol; 2007 Apr; 117(1):123-30. PubMed ID: 16890311
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
Ozdener F; Gülbas Z; Erol K; Ozdemir V
Methods Find Exp Clin Pharmacol; 2005; 27(6):395-400. PubMed ID: 16179957
[TBL] [Abstract][Full Text] [Related]
17. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
[TBL] [Abstract][Full Text] [Related]
18. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans.
Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A
Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917
[TBL] [Abstract][Full Text] [Related]
19. Changes in vitamin C and vitamin E during oxidative stress in myocardial reperfusion.
Sood R; Narang AP; Abraham R; Arora U; Calton R; Sood N
Indian J Physiol Pharmacol; 2007; 51(2):165-9. PubMed ID: 18175661
[TBL] [Abstract][Full Text] [Related]
20. 5-HT uptake in platelets of lithium-treated patients with affective disorders and of healthy controls.
Thies-Flechtner K; Weigel I; Müller-Oerlinghausen B
Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():4-6. PubMed ID: 7984700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
